MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 121 to 140 of 166,322 approvalsPage 7 of 8317

Gliclazide Sustained-release Tablets

Approval Number: 国药准字H20254382
Registration: May 27, 2025

Ropivacaine Hydrochloride Injection

Approval Number: 国药准字H20254307
Registration: May 27, 2025

Dobutamine Hydrochloride Injection

Approval Number: 国药准字H20254389
Registration: May 27, 2025

Luvometinib Tablets

Approval Number: 国药准字H20250026
Registration: May 27, 2025

Orlistat Capsules

Approval Number: 国药准字H20254244
Registration: May 27, 2025

Minoxidil Liniment

Approval Number: 国药准字H20254397
Registration: May 27, 2025

Nitroglycerin Injection

Approval Number: 国药准字H20254310
Registration: May 27, 2025

Nitroglycerin Injection

Approval Number: 国药准字H20254311
Registration: May 27, 2025

Ceftazidime and Avibactam Sodium for Injection

Approval Number: 国药准字H20254290
Registration: May 27, 2025

Levodopa and Benserazide Hydrochloride Tablets

Approval Number: 国药准字H20254401
Registration: May 27, 2025

Gecacitinib Hydrochloride Tablets

Approval Number: 国药准字H20250021
Registration: May 27, 2025

Apalutamide Tablets

Approval Number: 国药准字H20254353
Registration: May 27, 2025

Zanidatamab for Injection

Approval Number: 国药准字S20250030
Registration: May 27, 2025

Dacomitinib Tablets

Approval Number: 国药准字H20254268
Registration: May 27, 2025

Isosorbide Dinitrate Injection

Approval Number: 国药准字H20254355
Registration: May 27, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20254361
Registration: May 27, 2025

Haloperidol Injection

Approval Number: 国药准字H20254394
Registration: May 27, 2025

Trastuzumab rezetecan for Injection

Approval Number: 国药准字S20250024
Registration: May 27, 2025

Celecoxib Tablets

Approval Number: 国药准字H20254315
Registration: May 27, 2025

Tadalafil Tablets

Approval Number: 国药准字H20254297
Registration: May 27, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.